121 related articles for article (PubMed ID: 12210420)
1. Replication of enhancer-deficient amphotropic murine leukemia virus in human fibrosarcoma but not in primary human fibroblasts.
Reuss FU; Berdel B; Heber R; Bantel-Schaal U
J Med Virol; 2002 Oct; 68(2):278-84. PubMed ID: 12210420
[TBL] [Abstract][Full Text] [Related]
2. Replication of enhancer-deficient amphotropic murine leukemia virus in human cells.
Reuss FU; Berdel B; Ploss M; Heber R
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10898-903. PubMed ID: 11535815
[TBL] [Abstract][Full Text] [Related]
3. Amphotropic murine leukemia virus replication in human mammary epithelial cells and the formation of cytomegalovirus-promoter recombinants.
Reuss FU; Heber R; Ploss A; Berdel B
Virology; 2001 Dec; 291(1):91-100. PubMed ID: 11878879
[TBL] [Abstract][Full Text] [Related]
4. Enhancer-deficient amphotropic murine leukemia virus and recombinants with heterologous transcription elements can be efficiently amplified and detected in Mus dunni fibroblasts.
Reuss FU; Berdel B; Heber R; Ploss M
Gene Ther; 2002 Sep; 9(17):1183-8. PubMed ID: 12170382
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells.
Ploss M; Berdel B; Heber R; Reuss FU
J Med Virol; 2003 Feb; 69(2):267-72. PubMed ID: 12683417
[TBL] [Abstract][Full Text] [Related]
6. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus.
Kim S; Park EJ; Yu SS; Kim S
J Virol Methods; 2004 Jun; 118(1):1-7. PubMed ID: 15158062
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
[TBL] [Abstract][Full Text] [Related]
8. Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy.
Schwenter F; Déglon N; Aebischer P
J Gene Med; 2003 Mar; 5(3):246-57. PubMed ID: 12666190
[TBL] [Abstract][Full Text] [Related]
9. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
10. Efficient replication of full-length murine leukemia viruses modified at the dimer initiation site regions.
Aagaard L; Rasmussen SV; Mikkelsen JG; Pedersen FS
Virology; 2004 Jan; 318(1):360-70. PubMed ID: 14972561
[TBL] [Abstract][Full Text] [Related]
11. Amphotropic murine leukemia virus is preferentially attached to cholesterol-rich microdomains after binding to mouse fibroblasts.
Beer C; Pedersen L
Virol J; 2006 Apr; 3():21. PubMed ID: 16579862
[TBL] [Abstract][Full Text] [Related]
12. Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers.
Modin C; Lund AH; Schmitz A; Duch M; Pedersen FS
Virology; 2000 Dec; 278(2):368-79. PubMed ID: 11118360
[TBL] [Abstract][Full Text] [Related]
13. Murine leukemia virus (MLV) replication monitored with fluorescent proteins.
Sliva K; Erlwein O; Bittner A; Schnierle BS
Virol J; 2004 Dec; 1():14. PubMed ID: 15610559
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.
Mbisa JL; Nikolenko GN; Pathak VK
J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835
[TBL] [Abstract][Full Text] [Related]
15. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
Traister RS; Lynch WP
Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
[TBL] [Abstract][Full Text] [Related]
16. Caveola-dependent endocytic entry of amphotropic murine leukemia virus.
Beer C; Andersen DS; Rojek A; Pedersen L
J Virol; 2005 Aug; 79(16):10776-87. PubMed ID: 16051869
[TBL] [Abstract][Full Text] [Related]
17. Macropinocytosis is the entry mechanism of amphotropic murine leukemia virus.
Rasmussen I; Vilhardt F
J Virol; 2015 Feb; 89(3):1851-66. PubMed ID: 25428868
[TBL] [Abstract][Full Text] [Related]
18. Complementarity between RNA dimerization elements favors formation of functional heterozygous murine leukemia viruses.
Rasmussen S; Pedersen FS
Virology; 2004 Nov; 329(2):440-53. PubMed ID: 15518822
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of enhancer nuclear factor 1 (NF1) sites in plasmacytoma and osteopetrosis induction by Akv1-99 murine leukemia virus.
Sørensen KD; Sørensen AB; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
Virology; 2005 Apr; 334(2):234-44. PubMed ID: 15780873
[TBL] [Abstract][Full Text] [Related]
20. Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant.
Deichmann M; Huder JB; Kleist C; Näher H; Schüpbach J; Böni J
Arch Dermatol Res; 2005 Feb; 296(8):345-52. PubMed ID: 15630577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
